Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
Open Access
- 17 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 116 (7) , e87-e89
Abstract
The emergence and consequent impact of COVID-19 has led to clinicians and academics looking for evidence, with clinical controversies to parallel socio-economical and political ones.Keywords
This publication has 17 references indexed in Scilit:
- Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after InfectionScientific Reports, 2017
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 2017
- Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodellingEP Europace, 2016
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent MechanismHypertension, 2014
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injuryScientific Reports, 2014
- N-Terminal Pro-Brain Natriuretic Peptide and Angiotensin-Converting Enzyme-2 Levels and Their Association With Postoperative Cardiac Complications After Emergency Orthopedic SurgeryThe American Journal of Cardiology, 2012
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Myocardial infarction increases ACE2 expression in rat and humansEuropean Heart Journal, 2005
- Myocardial infarction increases ACE2 expression in rat and humansEuropean Heart Journal, 2005